Europe Human Growth Hormone Market Size & Outlook, 2023-2030
The human growth hormone market in Europe is expected to reach a projected revenue of US$ 4,155.4 million by 2030. A compound annual growth rate of 12.2% is expected of Europe human growth hormone market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,856.9
Forecast, 2030 (US$M)
$4,155.4
CAGR, 2024 - 2030
12.2%
Report Coverage
Europe
Related Markets
Europe human growth hormone market highlights
- The Europe human growth hormone market generated a revenue of USD 1,856.9 million in 2023.
- The market is expected to grow at a CAGR of 12.2% from 2024 to 2030.
- In terms of segment, growth hormone deficiency was the largest revenue generating application in 2023.
- Growth Hormone Deficiency is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 1,856.9 million |
| Market revenue in 2030 | USD 4,155.4 million |
| Growth rate | 12.2% (CAGR from 2023 to 2030) |
| Largest segment | Growth hormone deficiency |
| Fastest growing segment | Growth Hormone Deficiency |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Other Applications, Growth Hormone Deficiency |
| Key market players worldwide | Novo Nordisk A/S ADR, Eli Lilly and Co, Pfizer Inc, Sandoz Group AG ADR, Roche, Ferring, Ipsen SA, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.4% of the global human growth hormone market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,726.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Growth Hormone Market Scope
Human growth hormone market segmentation & scope
Human Growth Hormone Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sandoz Group AG ADR | View profile | - | - | - |
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Europe human growth hormone market size, by country, 2018-2030 (US$M)
Europe Human Growth Hormone Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
